Neue Empfehlungen für die Herzinsuffizie...

Laura Weisenburger spricht mit Christina Grünberg aus dem Hauptstadtbüro der Apotheken Umschau über den Medikamentenversand bei Hitze. 

Dennis Ballwieser spricht mit Anne Frieda Müller aus dem Hauptstadtbüro der Apotheken Umschau über den Wechsel im Gesundheitsministerium. 

Nach ein paar Wochen Pause gibt es hier wieder unsere täglichen Updates zu allem Wissenswerten für Health Professionals. 

Herzinsuffizienz: Leitliniengerecht und zeitgemäß behandeln 

Send us Fan MailIn this episode, Dr. Catherine Leurer interviews Dr. Stephanie Poon (Cardiologist) on the 2021 CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction.Host: Dr. Catherine LeurerGuest: ... Show More

<p>Drs Coats, Bozkurt, Metra, and Zieroth discuss important updates regarding the management of patients with heart failure.</p> <p>Credit available for this activity expires: 11/22/2022<br /> Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.medscape.org/vie ... Show More

<p>Three aspects of the recent AF guideline documents and a possible new treatment of POTS are the topics John Mandrola, MD, discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To read a partial transcript or to com ... Show More

This episode covers emergency medicine-related recommendations from the American Heart Association's (AHA) clinical guideline on atrial fibrillation: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation Circulation. 2023 Show notes and reference ... Show More

<p>SCAI consensus document on LAAC, semaglutide/tirzepatide disruption, NSAIDs, and interventional echocardiography are the topics discussed by John Mandrola, MD, on this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To read a ... Show More

More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit ... Show More

<p>An HRS meeting recap, Impella failure, sacubitril/valsartan, the purpose of trials, and a major breakthrough in evidence generation are the topics discussed by John Mandrola, MD in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>. ... Show More

<p>Suboptimal dosing of renin-angiotensin-aldosterone system inhibitors (RAASi) therapy is associated with doubling of mortality. Experts discuss new options for intensification of RAASi in heart failure with reduced ejection fraction (HFrEF).<br />   <br /> Credit available for ... Show More

<p>Two new papers on left atrial appendage occlusion, the promise of DNA, statins in the elderly, and SGLT2 inhibitors are the topics John Mandrola, MD, discusses in this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To read a ... Show More